BioSpace News Archive

Inspira Technologies Ltd., a leader in respiratory medical technology, announced that it has appointed Professor Benad Goldwasser as Chairman of the Board of Directors.

Core One Labs Inc. a research and technology company focused in life sciences and on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy is pleased to announce it has entered into a definitive agreement to acquire Ketamine Infusion Centers of Texas Inc., a US based health and wellness Ketamine Clinic.

Angion Biomedica Corp., a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, announced its management team will present at the H.C. Wainwright Global Life Sciences Conference and the Oppenheimer 31st Annual Healthcare Conference.

Fact.MR, a global research & consulting firm, in their latest edition of the report, indicated that the laryngeal papillomatosis treatment market is likely to reflect exponential expansion in 2021 and beyond.

According to the report, the global radiation dermatitis market was valued at ~US$ 400 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030.

Advancements in science and technology has aided in improving healthcare outcomes. With better diagnostic and treatment techniques at the behest, doctors are able to prevent patients from suffering and improve treatment process, time, and reduce expenditure.

Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions

Yokogawa Electric Corporation and Integrated Commissioning and Qualification Consultants, Corp. of Southborough announce that they have entered into a partnership agreement under which ICQ Consultants will provide consulting and engineering services for the installation, maintenance, qualification, and support of Yokogawa’s bioreactor systems and related products in the United States.

XPhyto Therapeutics Corp., is pleased to announce that it has placed the first order for its rapid point-of-care SARS-CoV-2 RT-PCR test system from its exclusive diagnostic development partner, 3a-diagnostics GmbH.

Fact.MR, a global research & consulting firm, in their updated edition of the report, indicated that the meniscus repair systems market is projected to foresee notable business growth in 2021 and beyond.